Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Narayanan

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2013
Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growthMuralimohan Yepuru, Zhongzhi Wu, Anand Kulkarni, et al.
Journal of Cancer Research and Clinical Oncology|May 8, 2020
Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1Yong Hoi Lee, Siew Wai Pang, Esther Revai Lechtich, et al.
Molecular and Cellular Biology|January 20, 2005
c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alphaHarish Srinivas, Denise M Juroske, Shailaja Kalyankrishna, et al.
Cancer Research|January 14, 2010
Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancerRamesh Narayanan, Muralimohan Yepuru, Adam T Szafran, et al.
Cancer Research|November 19, 2010
Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitorChien-Ming Li, Zhao Wang, Yan Lu, et al.
Nature Communications|August 10, 2020
ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancersWei Wang, Mingqi Li, Suriyan Ponnusamy, et al.
Expert Opinion on Therapeutic Patents|March 23, 2010
Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indicationsMichael L Mohler, Ramesh Narayanan, Christopher C Coss, et al.
Pharmaceutical Research|July 5, 2012
Orally bioavailable tubulin antagonists for paclitaxel-refractory cancerChien-Ming Li, Yan Lu, Jianjun Chen, et al.
Biomedicines|March 29, 2023
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate CancerFarhan Khan, Obianuju Mercy Anelo, Qandeel Sadiq, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2016
Pharmacologic activation of estrogen receptor β increases mitochondrial function, energy expenditure, and brown adipose tissueSuriyan Ponnusamy, Quynh T Tran, Innocence Harvey, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2013
Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growthMuralimohan Yepuru, Zhongzhi Wu, Anand Kulkarni, et al.
Journal of Cancer Research and Clinical Oncology|May 8, 2020
Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1Yong Hoi Lee, Siew Wai Pang, Esther Revai Lechtich, et al.
Molecular and Cellular Biology|January 20, 2005
c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alphaHarish Srinivas, Denise M Juroske, Shailaja Kalyankrishna, et al.
Cancer Research|January 14, 2010
Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancerRamesh Narayanan, Muralimohan Yepuru, Adam T Szafran, et al.
Cancer Research|November 19, 2010
Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitorChien-Ming Li, Zhao Wang, Yan Lu, et al.
Nature Communications|August 10, 2020
ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancersWei Wang, Mingqi Li, Suriyan Ponnusamy, et al.
Expert Opinion on Therapeutic Patents|March 23, 2010
Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indicationsMichael L Mohler, Ramesh Narayanan, Christopher C Coss, et al.
Pharmaceutical Research|July 5, 2012
Orally bioavailable tubulin antagonists for paclitaxel-refractory cancerChien-Ming Li, Yan Lu, Jianjun Chen, et al.
Biomedicines|March 29, 2023
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate CancerFarhan Khan, Obianuju Mercy Anelo, Qandeel Sadiq, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2016
Pharmacologic activation of estrogen receptor β increases mitochondrial function, energy expenditure, and brown adipose tissueSuriyan Ponnusamy, Quynh T Tran, Innocence Harvey, et al.
Pageof 8